Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)
Clinical trial NCT00127777 · UNKNOWN
Trial details
- NCT number
- NCT00127777
- Sponsor
- University Hospital, Saarland
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.